Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Pediatrix Medical (MD) Shares Repurchased (2016 - 2026)

Pediatrix Medical (MD) has disclosed Shares Repurchased for 12 consecutive years, with $64.0 million as the latest value for Q4 2025.

  • Quarterly Shares Repurchased rose 9859.25% to $64.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $86.7 million through Dec 2025, up 4990.02% year-over-year, with the annual reading at $86.7 million for FY2025, 4990.02% up from the prior year.
  • Shares Repurchased for Q4 2025 was $64.0 million at Pediatrix Medical, up from $20.9 million in the prior quarter.
  • The five-year high for Shares Repurchased was $64.4 million in Q2 2022, with the low at $11000.0 in Q2 2023.
  • Average Shares Repurchased over 5 years is $10.1 million, with a median of $1.0 million recorded in 2022.
  • The sharpest move saw Shares Repurchased skyrocketed 25556.57% in 2022, then tumbled 99.98% in 2023.
  • Over 5 years, Shares Repurchased stood at $2.5 million in 2021, then tumbled by 40.58% to $1.5 million in 2022, then tumbled by 90.95% to $133000.0 in 2023, then surged by 383.46% to $643000.0 in 2024, then surged by 9859.25% to $64.0 million in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $64.0 million, $20.9 million, and $209000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.